Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2012
10/11/2012WO2012137387A1 Method and device for measuring blend rate of biodiesel-fuel-blended light oil and ester rate of fame
10/11/2012WO2012137207A1 Methods of monitoring and analyzing metabolic activity profiles diagnostic and therapeutic uses of same
10/11/2012WO2012137202A1 Composition comprising an iron indicator attached to a microparticle and uses of same for quantifying non-transferrin bound iron (ntbi) and cellular labile iron (lci)
10/11/2012WO2012137186A1 An in vitro method for high throughput screening of genotoxic agents in eukaryotic cells
10/11/2012WO2012137180A2 Biomarkers of immunotherapy efficacy
10/11/2012WO2012137012A1 Crystal structure of an a2a adenosine receptor
10/11/2012WO2012137009A1 A device for detecting an analyte
10/11/2012WO2012136871A1 Method for diagnosing alzheimer's disease using sfrp1 as a biomarker
10/11/2012WO2012136863A1 Catalytic surface
10/11/2012WO2012136856A1 Biomarkers for sensitive detection of statin-induced muscle toxicity
10/11/2012WO2012136820A1 Anti-ve-cadherin autoantibodies as a biomarker of vascular alterations associated with disorders
10/11/2012WO2012136761A1 Process for the preparation of a sulfated derivative of 3,5-diiodo-o-[3-iodophenyl]-l-tyrosine
10/11/2012WO2012136737A1 Quantitative standard for mass spectrometry of proteins
10/11/2012WO2012136720A1 Analysing vitamin d metabolites in dried blood
10/11/2012WO2012136695A1 Device comprising rows of magnetic elements in channels and compartments
10/11/2012WO2012136552A1 ANTIBODIES SPECIFIC TO PYROGLUTAMATED Αβ
10/11/2012WO2012136549A1 Use of substituted 2,3-dihydroimidazo[1,2-c]quinazolines
10/11/2012WO2012136548A1 Biomarkers for acute kidney injury
10/11/2012WO2012136484A1 Process and apparatus for the measurement of the hardness and for the selection of agricultural products
10/11/2012WO2012136308A1 Mould simulator
10/11/2012WO2012136304A1 Pressure probe for detecting clathrates and the use thereof
10/11/2012WO2012136272A1 Biomarkers for sensitive detection of statin-induced muscle toxicity
10/11/2012WO2012135944A1 Protein kinase inhibitors
10/11/2012WO2012135937A1 Protein kinase inhibitors
10/11/2012WO2012135905A1 Tam receptor ligands, metabolites and precursors thereof in the detection and modulation of inflammatory neuropathological disease
10/11/2012WO2012135902A1 Protease activity assay
10/11/2012WO2012118444A9 Novel compounds with photoluminescnce properties and applications thereof
10/11/2012WO2012111028A3 Selective detection and analysis of small molecules
10/11/2012WO2012103250A3 Colon cancer gene expression signatures and methods of use
10/11/2012WO2012103124A3 Accelerated mixed gas integrity testing of porous materials
10/11/2012WO2012094394A3 Methods and compositions for assessing and treating adrenal diseases and disorders
10/11/2012WO2012089868A3 Determination of levels of immunogenic gluten peptides in human samples
10/11/2012WO2012088146A3 Biomarkers and uses thereof in prognosis and treatment strategies for right-side colon cancer disease and left-side colon cancer disease
10/11/2012WO2012085079A3 Device and method for determining objects in a colour photograph
10/11/2012WO2012081898A3 Marker for predicting stomach cancer prognosis and method for predicting stomach cancer prognosis
10/11/2012WO2012074372A3 A system for fruit grading and quality determination
10/11/2012WO2012070863A3 Method for detecting nucleic acids using a nucleic acid enzyme/molecular beacon
10/11/2012WO2012051109A3 Fluid compositional analysis by combined gas chromatographic and direct flash methods
10/11/2012WO2011119732A3 Method for integrin ligand discovery
10/11/2012US20120259105 Human papilloma virus probes for the diagnosis of cancer
10/11/2012US20120258998 Fusion genes in gastrointestinal cancer
10/11/2012US20120258920 Peptides and aptamers thereof as specific modulators of mutant p53 function
10/11/2012US20120258883 Method of using cytokine assays to diagnose, treat, and evaluate inflammatory and autoimmune diseases
10/11/2012US20120258880 Methods and/or Use of Oligonucleotide Conjugates for Assays and Flow Cytometry Detections
10/11/2012US20120258877 Identification of cancer biomarkers and phosphorylated proteins
10/11/2012US20120258876 Nucleic acid beacons for fluorescent in-situ hybridisation and chip technology
10/11/2012US20120258875 Methods and apparatus for characterizing polymeric mixtures
10/11/2012US20120258872 Prevention, treatment and diagnosis of diseases associated with beta-amyloid formation and/or aggregation
10/11/2012US20120258552 Homogeneous measurement method and measuring reagent
10/11/2012US20120258551 Stabilization of bio-sensors for in vivo applications
10/11/2012US20120258550 Regulation of autophagy pathway phosphorylation and uses thereof
10/11/2012US20120258546 Automated On-Instrument pH Adjustment
10/11/2012US20120258545 Measuring chemical properties of a sample fluid in dialysis systems
10/11/2012US20120258524 Annealing Curve Analysis In PCR
10/11/2012US20120258484 Cancer diagnosis marker using the aberrant glycosylation of a protein
10/11/2012US20120258478 Method of collecting specimen and method of diagnosing subject to detect upper digestive system disease
10/11/2012US20120258477 Fecal neopterin concentration measurement as an indicator of disease activity in inflammatory bowel disease
10/11/2012US20120258475 Recovery of rare cells using a microchannel apparatus with patterned posts
10/11/2012US20120258474 Methods of detecting dna damage
10/11/2012US20120258473 Method of collecting specimen and method of diagnosing subject to detect upper digestive system disease
10/11/2012US20120258471 Peptide marker for cancer diagnosis, and cancer diagnosis method using same
10/11/2012US20120258470 Compositions comprising a dehalogenase substrate and a radionuclide and methods of use
10/11/2012US20120258469 Methods And Devices For Using Mucolytic Agents Including N-Acetyl Cysteine (NAC)
10/11/2012US20120258468 Indicator agent for noninflammatory stress response and use thereof
10/11/2012US20120258466 Filtration device for assays
10/11/2012US20120258462 Combinations of tumor-associated antigens in diagnostics for various types of cancers
10/11/2012US20120258459 System and method for particle filtration
10/11/2012US20120258458 Interferon-like protein zcyto21
10/11/2012US20120258454 Bisulfite conversion of DNA
10/11/2012US20120258453 Nucleic acid probe-based diagnostic assays targeting ssra genes of prokaryotic and eukaryotic organisms
10/11/2012US20120258451 Laser isolation of viable cells
10/11/2012US20120258446 Universal Multi-Variant Detection System
10/11/2012US20120258445 Methods for using nanowire sensors
10/11/2012US20120258443 Methods for the detection of jc polyoma virus
10/11/2012US20120258217 Method of processing a juice and/or soda product
10/11/2012US20120258129 Mycobacterium tuberculosis fusion protein and uses thereof
10/11/2012US20120258127 Vaccine peptides
10/11/2012US20120258123 Biomarkers for sensitive detection of statin-induced muscle toxicity
10/11/2012US20120258119 Anti-fibroblast activation protein antibodies and methods and uses thereof
10/11/2012US20120258114 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
10/11/2012US20120258111 Compositions and methods for modulating rsv infection and immunity
10/11/2012US20120258108 Dual Variable Domain Immunoglobulins and Uses Thereof
10/11/2012US20120258107 Agents, Uses and Methods
10/11/2012US20120258106 Mutated anti-cd22 antibodies with increased affinity to cd22-expressing leukemia cells
10/11/2012US20120258100 Chimeric anti-ricin antibody
10/11/2012US20120258093 Vla-4 as a biomarker for prognosis and target for therapy in duchenne muscular dystrophy
10/11/2012US20120258088 Chimeric bacteriophage lysin with activity against staphylococci bacteria
10/11/2012US20120258084 Progenitor cells and uses thereof
10/11/2012US20120258069 Rgd-binding compounds and methods of use
10/11/2012US20120258045 Inhibitors and methods of treatment of cardiovascular diseases, and methods for identifying inhibitors
10/11/2012US20120258040 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations
10/11/2012US20120257188 Paper based spectrophotometric detection of blood hemoglobin concentration
10/11/2012US20120256102 Dye-conjugated dendrimers
10/11/2012US20120255875 Systems and methods for processing and transmitting sensor data
10/11/2012DE10332848B4 Mikroarrays immobilisierter Biomoleküle, deren Herstellung und Verwendung Microarrays of immobilized biomolecules, their preparation and use
10/11/2012DE102011007048A1 Sensor device e.g. mass sensor device, for use in complementary metal-oxide-semiconductor readout circuit, has evaluation unit for detecting jump arising as result of anharmonicity in resonance of mechanical oscillation of oscillator
10/11/2012DE102011001952A1 Vorrichtung und Verfahren zur Bestimmung der Koagulationszeit von Blut Apparatus and method for determining the coagulation time of blood
10/11/2012DE102011001855A1 Identifying water containing unstable chemical compounds, preferably compounds having insufficient connection with oxygen, and/or exhibiting unacceptable amount of humic substances, comprises supplying water to developer region
10/11/2012DE102010045491B4 Verfahren zum Nachweis von makromolekularen Silicium-organischen Verbindungen und Vorrichtung hierfür A method for detecting macromolecular silicon-organic compounds and apparatus therefor
10/11/2012CA2832565A1 Biomarkers predictive of therapeutic responsiveness to ifn.beta. and uses thereof
1 ... 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 ... 3937